Beth Israel Deaconess Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Beth Israel Deaconess Medical Center sits in the top decile of US sponsors by registered trial count (#75 of 15,742 sponsors by registered trial count).
Beth Israel Deaconess Medical Center: 488 sponsored US clinical trials, 66 recruiting.
Beth Israel Deaconess Medical Center sponsors 488 registered US clinical trials on ClinicalTrials.gov, 66 of them currently recruiting, and 321 completed. 45 of these trials are in Phase 3-4 (later-stage) and 144 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 8 trials.
Top-decile sponsor footprint
Beth Israel Deaconess Medical Center ranks in the top decile of sponsors by registered trial count (#75 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
321 of 380 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
488 total, page 3 of 10
Treating Schizophrenia by Correcting Abnormal Brain Development
NCT00179465
Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure
NCT02194582
Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices: The RAPTOR-CIED Study (Main Phase)
NCT07352657
REducing pSychological diSTress To Optimize Recovery of Elderly ICU Survivors and Caregivers (RESTORE-ICU)
NCT06867367
The CARDIOPROTECT Trial
NCT07654426
Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery
NCT07591610
Assessing DCog Short for Neurotoxicity in CAR-T
NCT07403812
PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy
NCT07516808
AMIE's Clinical Conversational Abilities in an Urgent Care Setting
NCT06911398
Non-invasive Point-Of-Care Hemoglobin Testing In An Obstetric Population
NCT06521840
Impact of High Versus Lower Oxygen Fraction Prior to Extubation on Postoperative Pulmonary Atelectasis Measured With EIT
NCT06538740
High-flow Nasal Oxygen Therapy for Advanced Endoscopy in High-risk Patients.
NCT06610461
Testing Conversation Aid in Practice
NCT06011434
Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE)
NCT06029244
Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).
NCT05997277
Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing
NCT06119308
Dexamethasone vs Ondansetron After Cesarean Delivery
NCT05692245
Multi-Component Prehabilitation for Major Elective Surgery
NCT05752474
BOTOX Effects on Seizure Severity and Susceptibility
NCT05605756
Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies
NCT05279898
Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids
NCT05128383
A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters
NCT05883332
Causal Lesion Network Guided Treatment of Bipolar Mania With Transcranial Electrical Stimulation
NCT05445466
Mindfulness Meditation for Insomnia
NCT04242771
Impact of Inner Engineering on Relationships
NCT05528978
Brain Age and Sleep Architecture in Meditators
NCT05513846
Yoga for Mental Health in Parkinson's Patients
NCT05335850
What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia
NCT05282186
Alcohol and Breast Cancer (ABC) Trial
NCT05423730
OPTiMASK: Comparison of Pre-oxygenation With Standard Face Mask Combined With High Flow Nasal Oxygen With Pre-oxygenation With Standard Face Mask Alone
NCT05495841
Effects of Blueberries in Older Adults
NCT05358210
Sodium Nitroprusside in Early Course Schizophrenia
NCT04986072
Individualized Vocational and Educational Support and Training for Clinical High Risk for Psychosis (InVEST)
NCT05114733
Use of Patient-Controlled Analgesia in Acute Pancreatitis
NCT04816877
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
NCT05803096
Intrathecal Morphine for Cesarean Delivery
NCT05069012
Improving Hallucinations by Targeting the rSTS With tES
NCT05165654
Yogic Breathing and Guided Meditation for Long Covid Symptoms
NCT05139979
The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry
NCT04822363
The Impact of a Novel Coaching Program on Medical Errors and Well-Being of Physicians
NCT05557981
Fremanezumab, Migraine and Sleep
NCT04693533
Feasibility of an Electrical Impedance Tomography Device for Pulmonary Function Testing in ALS Patients
NCT05287958
Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System
NCT04982406
Mind Body Intervention for COVID-19 Long Haul Syndrome
NCT04854772
Interactive Effects of Mindfulness and Slow-paced Breathing
NCT04866901
Assessing the Impact of Isha Kriya Meditation on Anxiety and Depression - a Pilot Study
NCT05065476
Profiling the Skin Microbiome in Response to Altreno in Acne Patients
NCT04548349
Assessment of Breathing Using an Under-bed Weighing Scale
NCT04736212
Home Air Purification for Eosinophilic COPD
NCT04252235
CBCT-Guided Navigational Bronchoscopy For Lung Nodules
NCT04758403
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 53 |
| Phase 2 | 91 |
| Phase 3 | 13 |
| Phase 4 | 32 |
Therapeutic Areas
What is open in the Beth Israel Deaconess Medical Center pipeline
66 recruiting of 488 indexed (14% open); 321 completed (66%).
Phase mix: 45 late (III/IV) vs 144 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Beth Israel Deaconess Medical Center: open-pipeline peers nationwide
Peers matched on 488 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Beth Israel Deaconess Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 488 trials (± recruiting share)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 490 trials · 10% recruiting
- Fred Hutchinson Cancer Center · 483 trials · 12% recruiting
- National Heart, Lung, and Blood Institute (NHLBI) · 501 trials · 12% recruiting
- H. Lee Moffitt Cancer Center and Research Institute · 502 trials · 16% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Wayne State University · 13% recruiting · 163 trials
- University of Michigan · 13% recruiting · 1,327 trials
- Albany Medical College · 13% recruiting · 52 trials
Related
What to do with this Beth Israel Deaconess Medical Center page
488 registered trials is a research-attention snapshot, not an endorsement of Beth Israel Deaconess Medical Center or any single study.
- 66 of Beth Israel Deaconess Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Beth Israel Deaconess Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Beth Israel Deaconess Medical Center pipeline card: 488 registered trials from official public datasets.Report a data error.